iRegMed aims to establish regenerative forms of therapy and to create an autonomous system that
in the iRegMed centers treats patients with biological and regenerative therapies,
develops new forms of therapy and conducts studies with iRegMed research,
trains doctors and medical staff via the iRegMed Academy.
With the cause- and non-symptomatic-centered treatment iRegMed strives for an actual increase in value for the patients with innovative forms of therapy.
The patented GOLDIC® Method is a highly anti-inflammatory therapy that regulates pain and activates and promotes the differentiation of the body's own stem cells. It is used in the iRegMed centres.
Since 2010, more than 2,500 patients with various inflammatory and degenerative diseases have been successfully treated in various fields: Rheumatology, orthopaedics, sports medicine, neurology, dermatology, dentistry and ophthalmology.
The first iRegmed center in Tegernsee
The first iRegMed centre opens in Gmund / Tegernsee on 06/15/2018.
PRIVATE EQUITY INVESTMENT:
ca. 2.000.000 EUR
Data optimally protected & optimally used
iRegMed's authentication model enables the distribution and authorization of public keys in peer-to-peer or automated blockchain mode and secure, anonymous data transfer.
The man-in-the-middle attack is the greatest historical challenge of asymmetric cryptography, the basis for an end-to-end encryption model. The blockchain technology offers the possibility for this.
Advantages of the electronic patient file
Complete data control of the patient
Increase in efficiency and treatment quality by recording all patient data in one file
Avoidance of false and double treatments
Transparency for research with complete anonymity
Maximum security through decentralized encryption without man-in-the-middle
Creation of an efficient insurance structure
Support for doctors and clinics and recommendations for patients (AI)